Aminophenols
eMolecules 567-62-4 | 2-AMINO-6-HYDROXYBENZOIC ACID | AstaTech | MFCD16999405 | 153.137 | C7H7NO3 | 95.000 | Nc1cccc(O)c1C(O)=O | 1g | 603096216
2-AMINO-6-HYDROXYBENZOIC ACID | AstaTech | 567-62-4 | MFCD16999405 | 153.137 | C7H7NO3 | 95.000 | Nc1cccc(O)c1C(O)=O | 1g | 603096216
Medchemexpress LLC AC-099 hydrochloride | 849335-07-5 | C9H9Cl2F3N4 | 50 MG
AC-099 hydrochloride (compound 3) is a selective NPFF2R full agonist (EC50=1189 nM) and NPFF1R partial agonist (EC50=2370 nM). It has been shown to attenuate spinal nerve ligation-induced hypersensitivity in rats. This product is for research use only.
- Storage for powder: -20°C for 3 years, 4°C for 2 years
- Storage in solvent: -80°C for 6 months, -20°C for 1 month
- Appearance: Solid, white to off-white
- Purity: 99.92%
- Molecular weight: 301.10
Medchemexpress LLC NNC 92-1687 | 1MG
NNC 92-1687 is a non-peptide competitive human glucagon receptor antagonist (IC50 20 M Ki 9 1 M) NNC 92-1687 can be used in the research of type 2 diabetes[1]
Medchemexpress LLC di-Pal-MTO | 1349197-90-5 | 98.4% | 917.27 | 5 MG
di-Pal-MTO is a palm oil-based lipid created by combining the anticancer agent mitoxantrone (MTO) with palmitoleic acid. When formulated into nanoparticles with mono-Pal-MTO in a 1:1 molar ratio, it demonstrates effective siRNA cell delivery and enhanced anticancer activity. This combination has been shown to significantly reduce tumor cell viability by 81% and tumor size by 83% in vitro, outperforming Lipofectamine 2000-mediated transfection.
- Palm oil-based lipid, combining mitoxantrone (MTO) and palmitoleic acid.
- Effective siRNA cell delivery, enhanced anticancer activity.
- Forms nanoparticles (1:1 molar ratio with mono-Pal-MTO) for effective siRNA delivery.
- Enhances in vitro antitumor activity, reducing tumor cell viability by 81% and tumor size by 83%.
![Medchemexpress LLC 7-[3-(4-(2,3-dimethylphenyl)piperazin-1-yl)propoxy]-1H-quinolin-2-one hydrochloride | 1329509-60-5 | 99.0% | 427.97 g·mol⁻¹ | C24H30ClN3O2 | 1 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000241642.png-250.jpg)
Medchemexpress LLC 7-[3-(4-(2,3-dimethylphenyl)piperazin-1-yl)propoxy]-1H-quinolin-2-one hydrochloride | 1329509-60-5 | 99.0% | 427.97 g·mol⁻¹ | C24H30ClN3O2 | 1 MG
OPC 4392 hydrochloride is a small-molecule dopamine receptor modulator used in preclinical pharmacology research. It functions as a presynaptic dopamine autoreceptor agonist and a postsynaptic D2 receptor antagonist, and has been applied in animal studies to reverse reserpine-induced dopamine depletion and reduce apomorphine-induced behaviors.
- Acts as presynaptic dopamine autoreceptor agonist and postsynaptic D2 antagonist.
- Demonstrated efficacy in reversing reserpine-induced dopamine depletion in animal studies.
- Inhibits apomorphine-induced stereotypic and climbing behaviors in rodent models.
- High purity (98.99%) suitable for research applications.
- White to off-white solid, convenient for handling and formulation.
- Recommended sealed storage away from moisture; in solvent store at -80°C for long-term preservation.
Cayman Chemical Acetaminophen Inhibitors
An analgesic and antipyretic compound; an inhibitor of COX-2 that is selective over COX-1 (IC50s = 113.7 and 25.8 µM, respectively, in human blood ex vivo); induces ferroptotic cell death in primary mouse hepatocytes; has a metabolite that depletes glutathione reserves in the liver
Medchemexpress LLC RS100329 hydrochloride (2,4(1H,3H)-pyrimidinedione derivative) | 1215654-26-4 | 99.6% | 462.89 | C20H26ClF3N4O3 | 1 ML
RS100329 hydrochloride is a potent, selective α1A-adrenoceptor antagonist provided for in vitro receptor pharmacology and biochemical assays. It is available as a pre-made 10 mM solution in DMSO (1 mL) and in multiple solid sizes, with accompanying analytical documentation for research use.
- Potent, selective α1A-adrenoceptor antagonist suitable for in vitro studies.
- Available as 10 mM DMSO solution (1 mL) and as solid in multiple mg sizes.
- High purity (99.57%) appropriate for biochemical assays.
- Molecular weight 462.89 and formula C20H26ClF3N4O3.
- Supplied with data sheet, certificate of analysis, and safety data sheet.
- Intended for research use; follow laboratory safety and SDS guidance.
Medchemexpress LLC Axc-715 hydrochloride | 2490497-93-1 | 99.5% | C18H26ClN5 | 10MG
AXC-715 hydrochloride is the hydrochloride salt of a small-molecule TLR7/TLR8 dual agonist used for preclinical immunology and oncology research. Supplied for research use only, it is described as an immune adjuvant and has been used in synthesis of antibody-adjuvant conjugates and in vivo antitumor models.
- Dual TLR7/TLR8 agonist activity for immune-modulating studies
- High purity (99.5%) for reproducible experimental results
- Hydrochloride salt form improves aqueous solubility relative to the free base
- Suitable for conjugation and formulation in antibody-adjuvant constructs
- Available in small-scale research quantities for preclinical work
- Storage recommendations provided for solid and solution forms to maintain stability
Medchemexpress LLC Bepridil hydrochloride | 68099-86-5 | MFCD00065498 | 99.8% | 403.0 g/mol | C24H35ClN2O | 25 MG
Bepridil hydrochloride is a non-selective calcium channel blocker with antianginal activity, commonly used in cardiovascular and ion channel research to study calcium-mediated cardiac effects. The compound is provided as the hydrochloride salt (CAS 68099-86-5) with molecular formula C24H35ClN2O and molecular weight 403.0 g/mol.
- Non-selective calcium channel blocker used in cardiac and ion channel studies.
- Useful for investigating calcium-dependent electrophysiology and myocardial contractility.
- Hydrochloride salt form enhances solubility for assay preparation.
- Intended for in vitro and ex vivo research applications.
- Well-characterized chemical identifiers: CAS 68099-86-5; molecular formula C24H35ClN2O; molecular weight 403.0 g/mol.